The protective effects of MOF-VVPP at the glomerular level can be suggested from the tendency to decrease proteinuria and the albumin/creatinine ratio, as well as from the significant reduction of the number of cases of exercise-related hematuria compared to the placebo. Here, ALB is linked to Hematuria.